CMS Issues First Request for Public Comments on the Medicare Drug Price Negotiation Program "Small Biotech" Exception - Due March 27, 2023 | Goodwin
The Inflation Reduction Act’s (“IRA”) drug price negotiation provisions have captured the pharmaceutical and biotech industry’s attention. In part, the IRA allows the Centers for...
Source: jdsupra.com